SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-16-038222
Filing Date
2016-08-30
Accepted
2016-08-30 16:34:08
Documents
1
Period of Report
2016-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 8741
  Complete submission text file 0001437749-16-038222.txt   10284
Mailing Address
Business Address
BLECH ISAAC (Reporting) CIK: 0000905536 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-24477 | Film No.: 161861020

Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Issuer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations